Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Language Development Via FOXP2 in Autism Spectrum Disorder: A Review

Author(s): Panpan Chen, Zhongying Li, Yanfei Li, Syed S. Ahmad, Mohammad A. Kamal and Xiao Huo*

Volume 26, Issue 37, 2020

Page: [4789 - 4795] Pages: 7

DOI: 10.2174/1381612826666200909141108

Price: $65

Abstract

Background: An increasing number of newborn children in numerous nations are enrolled in early childhood education programs, and instructors, in this way, assume a focal job in invigorating language improvement in these youthful kids. Kids with language issues are found to have a higher risk for future scholarly challenges and learning inabilities. Language advancement among kids is an intricate procedure and vital for correspondence. The shortcomings in the utilization of grammatical structures may lessen the useful utilization of language for verbally expressive kids with autism spectrum disorder and exacerbate troubles with academic and social expertise advancement.

Results: FOXP2, the single principal gene connected to a speech and language issue, is significant for the right execution of complex motor behaviors used for speech. In any case, changes in FOXP2 lead to a speech/language issue portrayed by childhood apraxia of speech. These days, language learning is fundamentally required for kids who need to move to different nations to pursue the instructive frameworks and be helpful individuals or residents of those nations.

Conclusion: The purpose of this study was to explore the role of FOXP2 in language disorder and its management for children’s language and communication development.

Keywords: autism, children, disease, FOXP2, language, teacher.

« Previous Next »
[1]
Chaimay B, Thinkhamrop B, Thinkhamrop J. Risk factors associated with language development problems in childhood-a literature review. J Med Assoc Thai 2006; 89(7): 1080-6.
[PMID: 16881445]
[2]
Tallal P, Ross R, Curtiss S. Familial aggregation in specific language impairment. J Speech Hear Disord 1989; 54(2): 167-73.
[http://dx.doi.org/10.1044/jshd.5402.167 ] [PMID: 2709834]
[3]
Busari JO, Weggelaar NM. How to investigate and manage the child who is slow to speak. BMJ 2004; 328(7434): 272-6.
[http://dx.doi.org/10.1136/bmj.328.7434.272 ] [PMID: 14751899]
[4]
Lo M, Chen PH. Working Memory Capacity as a Factor Influencing the Relationship between Language Outcome and Rehabilitation in Mandarin-Speaking Preschoolers with Congenital Hearing Impairment Front Psychol 2017.
[http://dx.doi.org/10.3389/fpsyg.2017.00357]
[5]
Ann E. Factors Influencing Spoken Language Outcomes in Children following Early Cochlear Implantation Møller AR (ed): Cochlear and Brainstem Implants. Adv Otorhinolaryngol. Basel, Karger 2006.
[6]
Lewis BA, Freebairn LA, Taylor HG. Academic outcomes in children with histories of speech sound disorders. J Commun Disord 2000; 33(1): 11-30.
[http://dx.doi.org/10.1016/S0021-9924(99)00023-4 ] [PMID: 10665511]
[7]
Redmond SM, Rice ML. The socioemotional behaviors of children with SLI: Social Adaptation or Social Deviance? J Speech Lang Hear Res 1998; 41(3): 688-700.
[http://dx.doi.org/10.1044/jslhr.4103.688 ] [PMID: 9638932]
[8]
Sasaki T, Okazaki Y, Akaho R, et al. Type of feeding during infancy and later development of schizophrenia. Schizophr Res 2000; 42(1): 79-82.
[http://dx.doi.org/10.1016/S0920-9964(99)00102-4 ] [PMID: 10706988]
[9]
Kim H. What is the prevalence of social skill, speech and language deficits in adolescents with significant psychiatric mental health problems? 2002.http://www.med. monash.edu.au/healthservices/cce/evidence/pdf/b/377.PDF
[10]
Fergusson DM, Woodward LJ. Breast feeding and later psychosocial adjustment. Paediatr Perinat Epidemiol 1999; 13(2): 144-57.
[http://dx.doi.org/10.1046/j.1365-3016.1999.00167.x ] [PMID: 10214606]
[11]
Kuhl PK, Conboy B, Padden D, Nelson T, Pruitt J. Early speech perception and later language development: Implications for the “critical period.”. Lang Learn Dev 2005; 1(3-4): 237-64.
[http://dx.doi.org/10.1080/15475441.2005.9671948]
[12]
Werker JF, Curtin S. PRIMIR: A developmental framework of infant speech processing. Lang Learn Dev 2005; 1(2): 197-234.
[http://dx.doi.org/10.1080/15475441.2005.9684216]
[13]
Fagan MK. Mean Length of Utterance before words and grammar: longitudinal trends and developmental implications of infant vocalizations. J Child Lang 2009; 36(3): 495-527.
[http://dx.doi.org/10.1017/S0305000908009070 ] [PMID: 18922207]
[14]
Braverman J, Dunn R, Vyshedskiy A. Development of the Mental Synthesis Evaluation Checklist (MSEC): A Parent-Report Tool for Mental Synthesis Ability Assessment in Children with Language Delay Children (Basel) 2018; 5(5).
[15]
Yordanova R, Ivanov I. Developmental performance of 5-year-old Bulgarian children-An example of translational neuroscience in practice. J Eval Clin Pract 2018; 24(4): 851-8.
[http://dx.doi.org/10.1111/jep.12919 ] [PMID: 29691944]
[16]
Head Zauche L, Darcy Mahoney AE, Thul TA, Zauche MS, Weldon AB, Stapel-Wax JL. The Power of Language Nutrition for Children’s Brain Development, Health, and Future Academic Achievement. J Pediatr Health Care 2017; 31(4): 493-503.
[http://dx.doi.org/10.1016/j.pedhc.2017.01.007 ] [PMID: 28641740]
[17]
Robertson CE, Baron-Cohen S. Sensory perception in autism. Nat Rev Neurosci 2017; 18(11): 671-84.
[http://dx.doi.org/10.1038/nrn.2017.112 ] [PMID: 28951611]
[18]
Rapin I, Dunn M. Update on the language disorders of individuals on the autistic spectrum. Brain Dev 2003; 25(3): 166-72.
[http://dx.doi.org/10.1016/S0387-7604(02)00191-2 ] [PMID: 12689694]
[19]
Allen DA, Rapin I. Language disorders in preschool children: predictors of outcome - a preliminary report -. Brain Dev 1980; 2(1): 73-80.
[http://dx.doi.org/10.1016/S0387-7604(80)80010-6 ] [PMID: 7416441]
[20]
Allen DA. Developmental language disorders in preschool children: clinical subtypes and syndromes. School Psych Rev 1989; 18: 442-51.
[21]
Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children. I: Clinical characteristics. Pediatrics 1991; 88(6): 1211-8.
[PMID: 1956739]
[22]
Smith JB, Klug JR, Ross DL, et al. Genetic-based dissection unveils the inputs and outputs of striatal patch and matrix compartments. Neuron 2016; 91(5): 1069-84.
[http://dx.doi.org/10.1016/j.neuron.2016.07.046 ] [PMID: 27568516]
[23]
Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990; 13(7): 244-54.
[http://dx.doi.org/10.1016/0166-2236(90)90104-I ] [PMID: 1695398]
[24]
Shepherd GM. Corticostriatal connectivity and its role in disease. Nat Rev Neurosci 2013; 14(4): 278-91.
[http://dx.doi.org/10.1038/nrn3469 ] [PMID: 23511908]
[25]
Peach RK. Acquired apraxia of speech: features, accounts, and treatment. Top Stroke Rehabil 2004; 11(1): 49-58.
[http://dx.doi.org/10.1310/ATNK-DBE8-EHUQ-AA64 ] [PMID: 14872399]
[26]
Square-Storer PAH, Sharon C, Roy EA. The dissociation of aphasia from apraxia of speech, ideomotor limb, and buccofacial apraxia. Adv Psychol 1990; 70(C): 451-76.
[http://dx.doi.org/10.1016/S0166-4115(08)60658-5]
[27]
Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001; 413(6855): 519-23.
[http://dx.doi.org/10.1038/35097076 ] [PMID: 11586359]
[28]
van Rhijn JR, Fisher SE, Vernes SC, Nadif Kasri N. Foxp2 loss of function increases striatal direct pathway inhibition via increased GABA release. Brain Struct Funct 2018; 223(9): 4211-26.
[http://dx.doi.org/10.1007/s00429-018-1746-6 ] [PMID: 30187194]
[29]
Smith SD. Genes, language development, and language disorders. Ment Retard Dev Disabil Res Rev 2007; 13(1): 96-105.
[http://dx.doi.org/10.1002/mrdd.20135 ] [PMID: 17326114]
[30]
Lai CS, Gerrelli D, Monaco AP, Fisher SE, Copp AJ. FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder. Brain 2003; 126(Pt 11): 2455-62.
[http://dx.doi.org/10.1093/brain/awg247 ] [PMID: 12876151]
[31]
Fisher SE, Vargha-Khadem F, Watkins KE, Monaco AP, Pembrey ME. Localisation of a gene implicated in a severe speech and language disorder. Nat Genet 1998; 18(2): 168-70.
[http://dx.doi.org/10.1038/ng0298-168 ] [PMID: 9462748]
[32]
Eising E, Carrion-Castillo A, Vino A, et al. A set of regulatory genes co-expressed in embryonic human brain is implicated in disrupted speech development. Mol Psychiatry 2019; 24(7): 1065-78.
[http://dx.doi.org/10.1038/s41380-018-0020-x ] [PMID: 29463886]
[33]
McCarthy NS, Clark ML, Jablensky A, Badcock JC. No association between common genetic variation in FOXP2 and language impairment in schizophrenia. Psychiatry Res 2019; 271: 590-7.
[http://dx.doi.org/10.1016/j.psychres.2018.12.016 ] [PMID: 30554107]
[34]
Sollis E, Deriziotis P, Saitsu H, et al. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders. Hum Mutat 2017; 38(11): 1542-54.
[http://dx.doi.org/10.1002/humu.23303 ] [PMID: 28741757]
[35]
Stroud JC, Wu Y, Bates DL, et al. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 2006; 14(1): 159-66.
[http://dx.doi.org/10.1016/j.str.2005.10.005 ] [PMID: 16407075]
[36]
Meredith LJ, Wang CM, Nascimento L, Liu R, Wang L, Yang WH. The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation. J Cell Biochem 2016; 117(2): 426-38.
[http://dx.doi.org/10.1002/jcb.25288 ] [PMID: 26212494]
[37]
Sia GM, Clem RL, Huganir RL. The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice. Science 2013; 342(6161): 987-91.
[http://dx.doi.org/10.1126/science.1245079 ] [PMID: 24179158]
[38]
Oswald F, Klöble P, Ruland A, et al. The FOXP2-Driven Network in Developmental Disorders and Neurodegeneration. Front Cell Neurosci 2017; 11: 212.
[http://dx.doi.org/10.3389/fncel.2017.00212 ] [PMID: 28798667]
[39]
Hashemi M, Azizinezhad M. Teaching English To Children: A Unique, Challenging Experience For Teachers, Effective Teaching Ideas. Procedia Soc Behav Sci 2011; 30: 2083-7.
[http://dx.doi.org/10.1016/j.sbspro.2011.10.405]
[40]
Asher J. Organizing Your Classroom for Successful Second Language Acquisition. Available at:. www.tprsource.com/asher.htm20062006.
[41]
Asher J. The Total Physical Response Approach to Learning Language Available at:. www.tprworld.com/organizing.htm2006
[42]
Hashemi M. Techniques in Teaching English to Children, Oral presentation. Toyserkan Branch, Iran: Islamic Azad University 2008.
[43]
Shin K. Ten Helpful Ideas for Teaching English to Young Learners English Teaching Forum Available at:. https://www.researchgate.net/publication/285295236_Ten_helpful_ideas_for_teaching_English_to_young_learners
[44]
Larsen, Diane and Freeman Technique and Principles in Language Teaching. 2nd ed. New York: Oxford University Press 2000.
[45]
Scoot WA, Ytreberg LH. Teaching English to Children. New York: Longman 1990.
[46]
Selin CM, Rice ML, Girolamo T, Wang CJ. Speech-Language Pathologists’ Clinical Decision Making for Children With Specific Language Impairment. Lang Speech Hear Serv Sch 2019; 50(2): 283-307.
[http://dx.doi.org/10.1044/2018_LSHSS-18-0017 ] [PMID: 30969904]
[47]
Holmer E, Heimann M, Rudner M. Computerized Sign Language-Based Literacy Training for Deaf and Hard-of-Hearing Children. J Deaf Stud Deaf Educ 2017; 22(4): 404-21.
[http://dx.doi.org/10.1093/deafed/enx023 ] [PMID: 28961874]
[48]
Trillingsgaard A, Ulsted Sørensen E, Nemec G, Jørgensen M. What distinguishes autism spectrum disorders from other developmental disorders before the age of four years? Eur Child Adolesc Psychiatry 2005; 14(2): 65-72.
[http://dx.doi.org/10.1007/s00787-005-0433-3 ] [PMID: 15793685]
[49]
Kumar B, Prakash A, Sewal RK, Medhi B, Modi M. Drug therapy in autism: a present and future perspective. Pharmacol Rep 2012; 64(6): 1291-304.
[http://dx.doi.org/10.1016/S1734-1140(12)70927-1 ] [PMID: 23406740]
[50]
Murphy E, Benítez-Burraco A. Language deficits in schizophrenia and autism as related oscillatory connectomopathies: An evolutionary account. Neurosci Biobehav Rev 2017; 83: 742-64.
[http://dx.doi.org/10.1016/j.neubiorev.2016.07.029 ] [PMID: 27475632]
[51]
Mody M, Belliveau JW. Speech and Language Impairments in Autism: Insights from Behavior and Neuroimaging. N Am J Med Sci (Boston) 2013; 5(3): 157-61.
[http://dx.doi.org/10.7156/v5i3p157 ] [PMID: 24349628]
[52]
Tager-Flusberg H, Kasari C. Minimally verbal school-aged children with autism spectrum disorder: the neglected end of the spectrum. Autism Res 2013; 6(6): 468-78.
[http://dx.doi.org/10.1002/aur.1329 ] [PMID: 24124067]
[53]
Sokol DK, Chen D, Farlow MR, et al. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol 2006; 21(6): 444-9.
[http://dx.doi.org/10.1177/08830738060210062201 ] [PMID: 16948926]
[54]
Ahmad SS, Akhtar S, Jamal QM, et al. Multiple Targets for the Management of Alzheimer’s Disease. CNS Neurol Disord Drug Targets 2016; 15(10): 1279-89.
[http://dx.doi.org/10.2174/1871527315666161003165855 ] [PMID: 27712576]
[55]
Ahmad SS, Khan H. Danish Rizvi SM, Ansari SA, Ullah R, Rastrelli L, Mahmood HM, Siddiqui MH. Computational Study of Natural Compounds for the Clearance of Amyloid-Beta: A Potential Therapeutic Management Strategy for Alzheimer’s Disease. Molecules 2019; 24(18)E3233
[http://dx.doi.org/10.3390/molecules24183233 ] [PMID: 31491967]
[56]
Ahmad SS, Khan S, Kamal MA, Wasi U. The structure and function of α, β and γ-Secretase as therapeutic target enzymes into the development of Alzheimer’s disease: A review. CNS Neurol Disord Drug Targets 2019; 18(9): 657-67.
[http://dx.doi.org/10.2174/1871527318666191011145941 ] [PMID: 31608840]
[57]
Ahmad SS, Kamal MA. Current Updates on the Regulation of Beta-Secretase Movement as a Potential Restorative Focus for Management of Alzheimer’s Disease. Protein Pept Lett 2019; 26(8): 579-87.
[http://dx.doi.org/10.2174/0929866526666190405125334 ] [PMID: 30950339]
[58]
Bhat S, Acharya UR, Adeli H, Bairy GM, Adeli A. Autism: cause factors, early diagnosis and therapies. Rev Neurosci 2014; 25(6): 841-50.
[http://dx.doi.org/10.1515/revneuro-2014-0056 ] [PMID: 25222596]
[59]
Food and Drug Administration FDA approves the first drug to treat irritability associated with autism, Risperdal 2006. Available at:. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108759.htm
[60]
Horvath K, Stefanatos G, Sokolski KN, Wachtel R, Nabors L, Tildon JT. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998; 9(1): 9-15.
[PMID: 9585670]
[61]
Bristol-Myers Squibb US. Food and Drug Administration approves Abilify (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients (ages 6 to 17 years). 2009.http://news.bms.com/press-release/rd-news/us-food-and-drug-administration-approves-abilify-aripiprazole-treatment-irrita
[62]
Fuentes-Albero M, Cauli O. Homocysteine Levels in Autism Spectrum Disorder: A Clinical Update. Endocr Metab Immune Disord Drug Targets 2018; 18(4): 289-96.
[http://dx.doi.org/10.2174/1871530318666180213110815 ] [PMID: 29437021]
[63]
Uvebrant P, Bauzienè R. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994; 25(6): 284-9.
[http://dx.doi.org/10.1055/s-2008-1073041 ] [PMID: 7770124]
[64]
Whitney O, Voyles T, Hara E, Chen Q, White SA, Wright TF. Differential FoxP2 and FoxP1 expression in a vocal learning nucleus of the developing budgerigar. Dev Neurobiol 2015; 75(7): 778-90.
[http://dx.doi.org/10.1002/dneu.22247 ] [PMID: 25407828]
[65]
Mukamel Z, Konopka G, Wexler E, et al. Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk. J Neurosci 2011; 31(32): 11437-42.
[http://dx.doi.org/10.1523/JNEUROSCI.0181-11.2011 ] [PMID: 21832174]
[66]
Vernes SC, Newbury DF, Abrahams BS, et al. A functional genetic link between distinct developmental language disorders. N Engl J Med 2008; 359(22): 2337-45.
[http://dx.doi.org/10.1056/NEJMoa0802828 ] [PMID: 18987363]
[67]
Roll P, Vernes SC, Bruneau N, et al. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet 2010; 19(24): 4848-60.
[http://dx.doi.org/10.1093/hmg/ddq415 ] [PMID: 20858596]
[68]
Chen YC, Kuo HY, Bornschein U, et al. Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c. Nat Neurosci 2016; 19(11): 1513-22.
[http://dx.doi.org/10.1038/nn.4380 ] [PMID: 27595386]
[69]
Vernes SC, Spiteri E, Nicod J, et al. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet 2007; 81(6): 1232-50.
[http://dx.doi.org/10.1086/522238 ] [PMID: 17999362]
[70]
MacDermot KD, Bonora E, Sykes N, et al. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genet 2005; 76(6): 1074-80.
[http://dx.doi.org/10.1086/430841 ] [PMID: 15877281]

Rights & Permissions Print Cite
Article Metrics
19
2
© 2024 Bentham Science Publishers | Privacy Policy